The top after-market NASDAQ gainers Monday were: Complete Genomics, Affymetrix, MCG Capital Corp, Urban Outfitters, Oncothyreon and Ctrip.com International. The top after-market NASDAQ losers were: Zoltek Companies, Nortek, Cavium, Team, Teva Pharmaceutical Industries and ArthroCare Corp.

Gainers

Complete Genomics, Inc. (GNOM) stock surged 3.65 percent to $3.12 in post market trading after climbing more than 6 percent in regular trading.

Affymetrix, Inc. (AFFX) stock gained 2.93 percent to $4.56 in aftermarket session. The company announced that it has signed a global distribution agreement with Almac Group Ltd. In which, Affymetrix has exclusive rights to distribute Almac's Xcel array for research use in biomarker discovery for multiple disease areas, including cancer.

MCG Capital Corp. (MCGC) stock advanced 2.74 percent to $4.50 in post market trading. The company stock advanced nearly 3 percent in regular trading.

Urban Outfitters, Inc. (URBN) stock rose 2.61 percent to $30.31 in aftermarket session. Analysts at Credit Suisse raised price target on shares of URBN to $32.00.

Oncothyreon Inc. (ONTY) stock gained 1.83 percent to $4.44 in post market session.

Ctrip.com International, Ltd. (CTRP) stock advanced 1.79 percent to $22.12 in post market session. The stock has a 52-week low of $21.01, a 52-week high of $50.57 and $3.13 billion in market capitalization.

Losers

Zoltek Companies, Inc. (ZOLT) stock slumped 6.86 percent to $10.59 in post market session.

Nortek Inc. (NTK) stock plunged 3.51 percent to $41.00 in post market trading. The stock has a 52-week low of $19.75, a 52-week high of $45.10 and $642.97 million in market capitalization.

Cavium, Inc. (CAVM) stock declined 2.42 percent to $29.83 in aftermarket session. The company currently expects that revenue in the first quarter of 2012 will be approximately 6 percent to 7 percent lower than revenue in the fourth quarter of 2011. The company also expects first quartet earning to be lower than prior estimation of $0.06 to $0.07 per share.

Team, Inc. (TISI) shares declined 2.19 percent to $32.58 in post market session. The company stock climbed nearly 8 percent in regular trading.

Teva Pharmaceutical Industries Ltd. (TEVA) stock fell 2.15 percent to $44.60 in post market trading. The company announced that it successfully priced its debut EUR 1 billion and CHF 450 million debt offerings, and that it entered into a JPY 100 billion (approximately $1.2 billion) senior unsecured fixed-rate syndicated term loan facility.

ArthroCare Corp. (ARTC) stock fell 1.87 percent to $26.19 in aftermarket session. The stock has a 52-week low of $23.54, a 52-week high of $36.00 and $736.37 million in market capitalization.

Credit Suisse Cancer Credit Suisse Cancer